Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dienogest for Endometriosis Pelvic Pain
CTR20150025Phase 3Suspended
- Sponsor
- Hangzhou Rongli Pharmaceutical Technology
- Start
- Jan 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of dienogest in endometriosis, sponsored by Hangzhou Rongli Pharmaceutical Technology. Started Jan 2015; status: suspended.
02
Drugs
dienogest
03
Conditions
endometriosis
Beyond the preview
Go deeper on CTR20150025.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20150025.